Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CATALYST BIOSCIENCES, INC.Financial_Report.xls
10-K - FORM 10-K - CATALYST BIOSCIENCES, INC.d273553d10k.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER, SECTION 906 - CATALYST BIOSCIENCES, INC.d273553dex321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER, SECTION 302 - CATALYST BIOSCIENCES, INC.d273553dex311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER, SECTION 302 - CATALYST BIOSCIENCES, INC.d273553dex312.htm
EX-10.2 (D) - THIRD LEASE AMENDMENT, WAKE FOREST UNIVERSITY HEALTH SCIENCES - CATALYST BIOSCIENCES, INC.d273553dex102d.htm
EX-10.15 - EXCLUSIVE LICENSE AGREEMENT - CATALYST BIOSCIENCES, INC.d273553dex1015.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER, SECTION 906 - CATALYST BIOSCIENCES, INC.d273553dex322.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

 

   

Registration Statement (Form S-8 No. 333-133882) pertaining to the Targacept, Inc. 2000 Equity Incentive Plan,

 

   

Registration Statements (Form S-8 No. 333-160331 and Form S-8 No. 333-133881) pertaining to the Targacept, Inc. 2006 Stock Incentive Plan, and

 

   

Registration Statement (Form S-3 No. 333-171346) of Targacept, Inc.;

of our reports dated March 06, 2012, with respect to the financial statements of Targacept, Inc. and the effectiveness of internal control over financial reporting of Targacept, Inc. included in this Annual Report (Form 10-K) of Targacept, Inc. for the year ended December 31, 2011.

/s/    Ernst & Young LLP        

Raleigh, North Carolina

March 06, 2012